Valuation: SenesTech, Inc.

Market Cap 6.18M 5.52M 5.08M 4.61M 8.73M 580M 8.95M 60.75M 24.21M 310M 23.21M 22.71M 977M P/E 2026 *
-0.84x
P/E 2027 * -1.07x
Enterprise Value 6.18M 5.52M 5.08M 4.61M 8.73M 580M 8.95M 60.75M 24.21M 310M 23.21M 22.71M 977M EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.18x
Free-Float
85.29%
Yield 2026 *
-
Yield 2027 * -
1 day+3.17%
1 week+8.57%
Current month+5.56%
1 month+70.20%
3 months-11.63%
6 months-34.10%
Current year-46.73%
1 week 1.05
Extreme 1.05
1.3
1 month 0.55
Extreme 0.55
1.33
Current year 0.55
Extreme 0.55
2.53
1 year 0.55
Extreme 0.55
3.4
3 years 0.55
Extreme 0.55
39.95
5 years 0.55
Extreme 0.55
3,888
10 years 0.55
Extreme 0.55
512,880.82
Manager TitleAgeSince
Chief Executive Officer 62 05/05/2026
Director of Finance/CFO 65 31/08/2015
Chief Tech/Sci/R&D Officer - 31/10/2024
Director TitleAgeSince
Chairman 52 06/05/2026
Director/Board Member 53 04/11/2020
Director/Board Member 47 04/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/10/26
Glenbrook Capital Management
BuyCompany 2,000 0.0369%
22/10/26
Glenbrook Capital Management
BuyCompany 7,500 0.1383%
19/10/26
Glenbrook Capital Management
BuyCompany 376,552 6.9429%
Change 5-day change 1-year change 3-year change Capi.($)
+3.17%+8.57%-66.37%-97.26% 6.18M
+1.17%+3.91%+27.82%+36.11% 34.25B
-2.76%+2.79%-11.31%+33.12% 17.84B
-0.09%-0.87%+45.41%+48.58% 17.45B
0.00%+0.09%-5.79%-15.43% 14.46B
+0.11%-.--%-.--%-.--% 12.96B
-0.90%+5.26%+14.15%+12.02% 11.14B
+0.21%+9.18%+3.03%+160.08% 9.9B
-0.22%-.--%-.--%-.--% 8.3B
+1.76%+1.59% - - 8.08B
Average +0.25%+3.03%+0.77%+19.69% 13B
Weighted average by Cap. -0.03%+2.36%+13.04%+33.02%

Financials

2026 *2027 *
Net sales 3.49M 3.11M 2.87M 2.6M 4.93M 327M 5.05M 34.28M 13.66M 175M 13.1M 12.82M 551M 5.24M 4.68M 4.3M 3.91M 7.4M 491M 7.59M 51.48M 20.52M 263M 19.66M 19.24M 828M
Net income -7.2M -6.43M -5.92M -5.37M -10.18M -675M -10.43M -70.77M -28.21M -361M -27.04M -26.46M -1.14B -6.22M -5.55M -5.11M -4.63M -8.78M -583M -9M -61.08M -24.34M -312M -23.33M -22.83M -982M
Net Debt - -
Projected Income Statement - Annual - SenesTech, Inc.
Logo SenesTech, Inc.
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Employees
24
Date Price Change Volume
09/11/26 US$1.140 +3.17% 19,226
06/11/26 US$1.105 -5.56% 65,570
05/11/26 US$1.170 -3.31% 135,905
04/11/26 US$1.210 -2.42% 100,371
03/11/26 US$1.240 +18.10% 598,822
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - SenesTech, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.140USD
Average target price
7.500USD
Spread / Average Target
+557.89%
  1. Stock Market
  2. Stocks
  3. SNES Stock